Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 2
1953 1
1955 1
1956 2
1957 2
1958 3
1959 2
1960 2
1961 2
1962 1
1964 2
1965 2
1966 1
1967 3
1968 1
1969 4
1970 6
1971 10
1972 11
1973 11
1974 10
1975 13
1976 8
1977 9
1978 6
1979 14
1980 5
1981 7
1982 10
1983 14
1984 10
1985 14
1986 15
1987 12
1988 13
1989 8
1990 6
1991 9
1992 3
1993 8
1994 12
1995 6
1996 9
1997 11
1998 2
1999 6
2000 8
2001 5
2002 7
2003 4
2004 6
2005 5
2006 4
2007 3
2008 5
2009 8
2010 3
2011 1
2012 2
2013 2
2014 2
2015 2
2016 6
2017 7
2018 9
2019 10
2020 5
2021 11
2022 6
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

426 results

Results by year

Filters applied: . Clear all
Page 1
Reactive astrocytes promote proteostasis in Huntington's disease through the JAK2-STAT3 pathway.
Abjean L, Ben Haim L, Riquelme-Perez M, Gipchtein P, Derbois C, Palomares MA, Petit F, Hérard AS, Gaillard MC, Guillermier M, Gaudin-Guérif M, Aurégan G, Sagar N, Héry C, Dufour N, Robil N, Kabani M, Melki R, De la Grange P, Bemelmans AP, Bonvento G, Deleuze JF, Hantraye P, Flament J, Bonnet E, Brohard S, Olaso R, Brouillet E, Carrillo-de Sauvage MA, Escartin C. Abjean L, et al. Among authors: flament j. Brain. 2023 Jan 5;146(1):149-166. doi: 10.1093/brain/awac068. Brain. 2023. PMID: 35298632
Ipilimumab-induced severe meningoradiculitis.
Lacour M, Grangeon L, Flament J, Duval-Modeste AB, Zaréa A, Guillaume M, Lefaucheur R. Lacour M, et al. Among authors: flament j. J Clin Neurosci. 2019 Apr;62:246-247. doi: 10.1016/j.jocn.2018.12.009. Epub 2018 Dec 28. J Clin Neurosci. 2019. PMID: 30598268 No abstract available.
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials.
Maurer MJ, Habermann TM, Shi Q, Schmitz N, Cunningham D, Pfreundschuh M, Seymour JF, Jaeger U, Haioun C, Tilly H, Ghesquieres H, Merli F, Ziepert M, Herbrecht R, Flament J, Fu T, Flowers CR, Coiffier B. Maurer MJ, et al. Among authors: flament j. Ann Oncol. 2018 Aug 1;29(8):1822-1827. doi: 10.1093/annonc/mdy203. Ann Oncol. 2018. PMID: 29897404 Free PMC article.
The inguinal rings.
Avisse C, Delattre JF, Flament JB. Avisse C, et al. Among authors: flament jb. Surg Clin North Am. 2000 Feb;80(1):49-69. doi: 10.1016/s0039-6109(05)70397-2. Surg Clin North Am. 2000. PMID: 10685144 Review.
[Cephalic zona].
Bronner A, Gerhard JP, Flament J. Bronner A, et al. Among authors: flament j. Rev Otoneuroophtalmol. 1972 Oct-Dec;44(5):431-2. Rev Otoneuroophtalmol. 1972. PMID: 4542219 French. No abstract available.
CRYSTAL23: A Program for Computational Solid State Physics and Chemistry.
Erba A, Desmarais JK, Casassa S, Civalleri B, Donà L, Bush IJ, Searle B, Maschio L, Edith-Daga L, Cossard A, Ribaldone C, Ascrizzi E, Marana NL, Flament JP, Kirtman B. Erba A, et al. Among authors: flament jp. J Chem Theory Comput. 2022 Dec 11. doi: 10.1021/acs.jctc.2c00958. Online ahead of print. J Chem Theory Comput. 2022. PMID: 36502394 Review.
[Update on Bardet-Biedl syndrome].
Dollfus H, Verloes A, Bonneau D, Cossée M, Perrin-Schmitt F, Brandt C, Flament J, Mandel JL. Dollfus H, et al. Among authors: flament j. J Fr Ophtalmol. 2005 Jan;28(1):106-12. doi: 10.1016/s0181-5512(05)81032-0. J Fr Ophtalmol. 2005. PMID: 15767906 Review. French.
A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 'CREATE' trial.
Péron J, Marreaud S, Staelens D, Raveloarivahy T, Nzokirantevye A, Flament J, Steuve J, Lia M, Collette L, Schöffski P. Péron J, et al. Among authors: flament j. Eur J Cancer. 2019 Mar;109:192-195. doi: 10.1016/j.ejca.2018.12.013. Epub 2019 Jan 14. Eur J Cancer. 2019. PMID: 30655100 Clinical Trial. No abstract available.
426 results